Literature DB >> 26003203

Does lymph node ratio affect prognosis in gastroesophageal cancer?

Marcovalerio Melis1, Antonio Masi2, Antonio Pinna3, Steven Cohen2, Ioannis Hatzaras2, Russell Berman2, Leon H Pachter2, Elliot Newman2.   

Abstract

BACKGROUND: Increasing evidence suggests that the ratio of number of nodes harboring metastatic cancer to the total number of lymph nodes examined (lymph node ratio, LNR) may affect survival after esophagogastric resection for cancer. We analyzed the impact of LNR in overall survival in patients undergoing esophagogastric resection for cancer.
METHODS: Patients who underwent gastroesophageal resection for cancer (1998 to 2008) were categorized into 4 groups according to their LNR: 113 patients had negative nodes (N0), 86 LNR less than .3, 40 LNR .31 to .6, and 47 LNR greater than .6. Study endpoint was overall median survival.
RESULTS: Higher LNR was associated (P < .001) with more advanced stage and adverse pathologic features (eg, grading, venous/perineural invasion). Multivariate analysis demonstrated that LNR is an independent predictor of survival.
CONCLUSION: In our experience, LNR correlates with adverse pathologic features and is a negative prognostic factor in patients undergoing radical resection for gastroesophageal cancer. Published by Elsevier Inc.

Entities:  

Keywords:  Gastroesophageal cancer; Lymph node ratio; Prognosis

Mesh:

Year:  2015        PMID: 26003203     DOI: 10.1016/j.amjsurg.2014.12.042

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  8 in total

1.  Impact of Lymph Node Sampling in Stage II and III Epithelial Ovarian Cancer Patients with Clinically Negative Lymph Nodes.

Authors:  Mohamed Ibrahim Fahim; Abdelmaksoud Mohamed Ali; Rasha Mahmoud Allam
Journal:  Indian J Surg Oncol       Date:  2019-12-02

Review 2.  Prognostic impact of nodal status and therapeutic implications.

Authors:  Katja Ott; Susanne Blank; Laura Ruspi; Margit Bauer; Leila Sisic; Thomas Schmidt
Journal:  Transl Gastroenterol Hepatol       Date:  2017-03-15

3.  Lymph Node Ratio Is an Independent Prognostic Factor for Patients with Siewert Type II Adenocarcinoma of Esophagogastric Junction: Results from a 10-Year Follow-up Study.

Authors:  Yuling Zhang; Ditian Liu; Chunfa Chen
Journal:  J Gastrointest Cancer       Date:  2021-09

4.  Clinical Influence of the Lymph Node Ratio on Lymph Node Metastasis-positive Gastric Cancer Patients Who Receive Curative Treatment.

Authors:  Toru Aoyama; Kesikeu Komori; Ayako Tamagawa; Masato Nakazano; Kentaro Hara; Itaru Hashimoto; Hiroshi Tamagawa; Kenki Segami; Yukio Maezawa; Kazuki Kano; Takashi Oshima; Norio Yukawa; Yasushi Rino
Journal:  In Vivo       Date:  2022 Mar-Apr       Impact factor: 2.155

5.  Gastrectomy with D2 Lymphadenectomy for Carcinoma of the Stomach in a Stand-alone Cancer Centre in Rural India.

Authors:  Nizamudheen Mangalasseri Pareekutty; Sachin Kadam; Basavaraj Ankalkoti; Satheesan Balasubramanian; Bindu Anilkumar
Journal:  Indian J Surg Oncol       Date:  2020-05-10

6.  Prognostic value of lymph node ratio in stage IIIC epithelial ovarian cancer with node-positive in a SEER population-based study.

Authors:  Juan Zhou; Zhen-Yu He; Feng-Yan Li; Jia-Yuan Sun; Huan-Xin Lin; San-Gang Wu; Qiong-Hua Chen
Journal:  Oncotarget       Date:  2016-02-16

7.  Superiority of lymph node ratio-based staging system for prognostic prediction in 2575 patients with gastric cancer: validation analysis in a large single center.

Authors:  Lin-Yong Zhao; Chang-Chun Li; Lu-Yu Jia; Xiao-Long Chen; Wei-Han Zhang; Xin-Zu Chen; Kun Yang; Kai Liu; Yi-Gao Wang; Lian Xue; Bo Zhang; Zhi-Xin Chen; Jia-Ping Chen; Zong-Guang Zhou; Jian-Kun Hu
Journal:  Oncotarget       Date:  2016-08-09

8.  Nodal staging score and adequacy of nodal staging.

Authors:  Hui-Min Chen; Ge Feng
Journal:  Onco Targets Ther       Date:  2019-01-08       Impact factor: 4.147

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.